Amikacin Injection Uses, Dosage, Side Effects and Interactions
Amikin
Amikin was the first amikacin injection product the FDA approved, in 1981. The FDA now lists it as discontinued; generic amikacin injection is still listed.
Amikacin Injection is an aminoglycoside antibiotic given by injection or IV for short-term treatment of serious infections caused by susceptible Gram-negative bacteria, and in some cases staphylococci.
Quick links
Ask Anything About Amikacin InjectionType a question in your own words. Answered from its FDA label in seconds.Every other section of this page is in the dots on the left edge of your screen: point at one to see where it goes.Every other section of this page is one tap away: use the arrow tab on the left edge of your screen.
Amikacin Injection in Short
- Drug class Aminoglycoside Antibacterial How the FDA classifies it
What it treatsAmikacin Injection is used for short-term treatment of serious bacterial infections, mainly those caused by Gram-negative bacteria that are susceptible to it. It may be started before lab results are back when a Gram-negative infection is suspected.
- How you get it Prescription only
- Comes asInjection (into a muscle, into a vein)
- The FDA’s strongest warningBoxed warning The FDA’s most serious alert. Read what it says
- What pharmacies pay
- Generic versionYes, FDA-approved Listed with the FDA, which does not mean every pharmacy stocks it
The Pharmacist’s Take
Amikacin is an aminoglycoside antibiotic, used since the early 1980s and with FDA-approved generics listed, that stops Gram-negative bacteria from making proteins and resists some enzymes that defeat gentamicin and tobramycin, so it is usually kept for serious or resistant infections treated in the hospital. For many people a short course brings few side effects they notice, mostly nausea, headache or a rash, but its biggest risks are ones you may not feel. Its boxed warning covers permanent hearing loss, balance problems and kidney damage, so tell the care team right away about ringing or roaring in the ears, dizziness or much less urine.
Key Takeaways From the HelloPharmacist Team
- Your care team gives it into a muscle or vein two or three times a day, usually for 7 to 10 days.
- Expect regular blood tests for kidney function and drug levels, plus hearing checks, because the dose is tuned to your weight and kidneys.
- Report ringing in the ears, muffled hearing or unsteadiness even after the last dose, because hearing damage can surface after treatment ends.
- Tell the team if you take a water pill such as furosemide or have kidney problems, since both raise the risk of hearing and kidney damage.
FDA Boxed WarningThe FDA’s strongest safety alert. Read what it says about Amikacin Injection.
Amikacin can cause permanent hearing loss, balance problems and kidney damage. People should be closely watched during treatment.
Risk is higher with existing kidney problems, high doses, long treatment (safety beyond 14 days is not established), older age, and dehydration. Hearing damage may not cause symptoms until after the drug is stopped.
Watch for dizziness, vertigo, ringing or roaring in the ears, hearing loss, numbness, tingling, muscle twitching, and seizures. Breathing muscle weakness can happen, especially with anesthetics or muscle relaxants. Avoid other drugs that harm the ears or kidneys, and strong diuretics such as furosemide. Your team should check kidney function, drug levels and hearing, and may stop or adjust the drug.
Patient Information Guide for Amikacin Injection
What It’s Used For
Amikacin Injection treats serious bacterial infections for a short time.
- Serious infections from susceptible Gram-negative bacteria (including Pseudomonas, E. coli, Proteus, Klebsiella, Enterobacter, Serratia, Acinetobacter)
- Bacterial septicemia, including neonatal sepsis
- Serious infections of the respiratory tract, bones and joints, central nervous system (including meningitis), and skin and soft tissue
- Intra-abdominal infections, including peritonitis
- Burns and postoperative infections
- Serious complicated and recurrent urinary tract infections
- Certain staphylococcal infections under specific conditions
How It Works
Amikacin is an aminoglycoside antibiotic. It binds to the ribosome in bacteria and blocks protein production, which kills susceptible bacteria.
It resists some bacterial enzymes that inactivate gentamicin, tobramycin and kanamycin. It does not work against Salmonella and Shigella in patients, and has low activity against Gram-positive bacteria other than staphylococci.
Drug Class
Drug Class
- Aminoglycoside Antibacterial
Detailed classifications and sources
The FDA sorts a drug’s active ingredient by how it works, what it does in the body and its chemical structure, and gives it one main drug class.
Drug Class
Established Pharmacologic Class (EPC)- Aminoglycoside Antibacterial
The main drug class the FDA gives it. It is the class named on the drug’s label.
How It Works
Mechanism of action (MoA)None listed for Amikacin Injection in the FDA’s index.
What it does at the smallest level, such as a receptor or enzyme it blocks or switches on.
What It Does in the Body
Physiologic effect (PE)None listed for Amikacin Injection in the FDA’s index.
From our Patient Information GuideAmikacin is an aminoglycoside antibiotic. It binds to the ribosome in bacteria and blocks protein production, which kills susceptible bacteria. It resists some bacterial enzymes that inactivate gentamicin, tobramycin and kanamycin. Read How Amikacin Injection Works
A change it makes in how the body works.
Chemical Family
Chemical structure (CS)- Aminoglycosides
The chemical family it belongs to, by its structure.
Drug Family
WHO ATC classification- Other antibiotics for topical use
- Other aminoglycosides
- Antibiotics
How the World Health Organization groups it: by the part of the body it acts on and what it treats.
The classes are the FDA’s own words, from its index of drug labels, published in the National Library of Medicine’s RxClass. The description under What It Does in the Body is written by the HelloPharmacist team, not the FDA. Read the FDA’s definitions. The drug family is the World Health Organization’s ATC classification. Reference only, not medical advice.
Dosage
Amikacin Injection is given by a healthcare professional into a muscle or a vein.
- Usually 2 or 3 times a day, with dose based on body weight
- Usual course is 7 to 10 days
- Kidney problems mean a lower dose or longer gaps between doses
- Blood levels and kidney function are checked during treatment
Follow your prescriber and the label.
Typical Doses
Your prescriber chooses your dose, so take it exactly as prescribed.
Serious infections caused by susceptible Gram-negative bacteria
Adults and children, 45 kg (99 lbs) Usual dose 337.5 mg every 12 hours
- 337.5 mg (7.5 mg/kg q12h) or 225 mg (5 mg/kg q8h)
Adults and children, 50 kg (110 lbs) Usual dose 375 mg every 12 hours
- 375 mg (7.5 mg/kg q12h) or 250 mg (5 mg/kg q8h)
Adults and children, 55 kg (121 lbs) Usual dose 412.5 mg every 12 hours
- 412.5 mg (7.5 mg/kg q12h) or 275 mg (5 mg/kg q8h)
Adults and children, 60 kg (132 lbs) Usual dose 450 mg every 12 hours
- 450 mg (7.5 mg/kg q12h) or 300 mg (5 mg/kg q8h)
Adults and children, 65 kg (143 lbs) Usual dose 487.5 mg every 12 hours
- 487.5 mg (7.5 mg/kg q12h) or 325 mg (5 mg/kg q8h)
Adults and children, 70 kg (154 lbs) Usual dose 525 mg every 12 hours
- 525 mg (7.5 mg/kg q12h) or 350 mg (5 mg/kg q8h)
Adults and children, 75 kg (165 lbs) Usual dose 562.5 mg every 12 hours
- 562.5 mg (7.5 mg/kg q12h) or 375 mg (5 mg/kg q8h)
Adults and children, 80 kg (176 lbs) Usual dose 600 mg every 12 hours
- 600 mg (7.5 mg/kg q12h) or 400 mg (5 mg/kg q8h)
Adults and children, 85 kg (187 lbs) Usual dose 637.5 mg every 12 hours
- 637.5 mg (7.5 mg/kg q12h) or 425 mg (5 mg/kg q8h)
Adults and children, 90 kg (198 lbs) Usual dose 675 mg every 12 hours
- 675 mg (7.5 mg/kg q12h) or 450 mg (5 mg/kg q8h)
Newborns · Loading dose Starting dose 10 mg/kg once
- Loading dose of 10 mg/kg initially
What a loading dose is: A larger dose given at the start to quickly build the medicine up to an effective level in the body.
Newborns · After loading dose Usual dose 7.5 mg/kg every 12 hours Highest dose 15 mg/kg/day
Good to know
Usual duration of treatment is 7 to 10 days
What a loading dose is: A larger dose given at the start to quickly build the medicine up to an effective level in the body.
Adults, children and older infants with normal kidney function Usual dose 7.5 mg/kg every 12 hours Highest dose 1.5 gram a day
- 15 mg/kg/day divided into 2 or 3 equal doses at equally-divided intervals, i.e., 7.5 mg/kg q12h or 5 mg/kg q8h
Good to know
Usual duration of treatment is 7 to 10 days
Urinary tract infections
Usual dose 250 mg twice a day
- 250 mg twice daily may be used
Side Effects
The most important side effects involve the ears, balance and kidneys.
Common side effects
- Hearing loss or ringing in the ears
- Dizziness or loss of balance
- Changes in kidney function tests
- Skin rash
- Drug fever
- Headache
- Nausea and vomiting
- Numbness, tingling or tremor
- Kidney changes, usually reversible after stopping
When to get medical help
- Tell your care team right away about hearing changes, ringing or roaring in the ears, dizziness, or vertigo (spinning feeling).
- Report much less urine, swelling, or other signs of kidney trouble.
- Get urgent help for trouble breathing or muscle weakness or paralysis.
- Report numbness, skin tingling, muscle twitching or seizures.
- Call your doctor about diarrhea during or even months after treatment, since it can be a serious C. difficile infection.
- Seek emergency help for allergic reactions such as wheezing or swelling, especially if you have asthma or sulfite sensitivity.
Report hearing or balance changes, reduced urination, breathing problems, or lasting diarrhea right away.
Warnings and Precautions
- Permanent hearing loss and kidney damage are the biggest risks, especially with kidney disease, high doses, long treatment, older age or dehydration.
- Breathing muscle weakness can occur, particularly with anesthetics or muscle relaxants.
- Can harm an unborn baby.
- Contains sodium metabisulfite, which can cause allergic reactions.
- C. difficile diarrhea can occur, even months later.
- Certain mitochondrial gene variants raise the risk of hearing loss even at normal drug levels.
Interactions
Some drugs add to amikacin's risk of ear, kidney or nerve damage.
- Other aminoglycosides, vancomycin, polymyxin B, colistin, cisplatin, amphotericin B, bacitracin: more kidney and nerve toxicity
- Furosemide and ethacrynic acid: can cause hearing damage and raise amikacin toxicity
- Anesthetics and muscle relaxants: higher risk of breathing muscle weakness
- Large transfusions of citrate-anticoagulated blood: same risk
Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.
Before You Start
- Do not use with a past allergy to amikacin or another aminoglycoside.
- Tell your doctor about kidney disease.
- Mention any personal or maternal history of hearing loss from aminoglycosides.
- Tell your doctor if you are pregnant.
- Mention asthma or sulfite allergy.
- Older adults and dehydrated people are at higher risk.
Overdose
In overdose or a toxic reaction, hemodialysis or peritoneal dialysis helps remove amikacin from the blood. In newborns, exchange transfusion may also be considered.
Half-Life and How Your Body Processes It
Amikacin is absorbed quickly after a muscle injection, reaching peak blood levels in about 1 hour. The half-life is a little over 2 hours in people with normal kidneys. It is cleared mostly unchanged by the kidneys, with about 98% in urine within 24 hours after an injection into a muscle. With kidney impairment it clears much more slowly, so doses are adjusted. It reaches many tissues and fluids and crosses the placenta.
Storage
Store at 20° to 25°C (68° to 77°F).
Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI
Amikacin Injection: Pharmacist Answers to Common Questions
Quick, plain-English answers to the questions patients ask most about Amikacin Injection — the kind of thing our pharmacy team would talk through with you at the counter.
What is amikacin injection used for?
How long will I be on amikacin injection?
What side effects should I call about?
Can I take it with other medicines?
Is amikacin injection safe in pregnancy?
What if I miss a dose?
Is amikacin injection available over the counter?
When was amikacin injection first available?
Who makes amikacin injection?
What is the brand name of amikacin injection?
What is the generic name of Amikin?
What drug class is amikacin injection?
Is there a generic version of amikacin injection?
What strengths does amikacin injection come in?
How much does amikacin injection cost?
Where can I read the amikacin injection prescribing information (package insert)?
Is amikacin injection gluten free?
Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI
Ask Anything About Amikacin Injection
Skip the scrolling. Ask in your own words and get an answer from Amikacin Injection’s FDA label and our pharmacists’ own work.
Name another drug or a supplement in your question and we check both.
AI answers from FDA labels and our own records, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.How this works
- Sources: Amikacin Injection’s FDA label, including the clinical studies it reports, and the label of any drug you name; our pharmacists’ own work, such as our Do Not Crush list and our published answers to readers’ questions; our pharmacy prices and the Natural Medicines supplement database.
- Written by AI: Answers are written by AI from those sources, and AI can make mistakes. Check what you read here with your doctor or pharmacist before you act on it.
- Reviewed afterward: Our pharmacy team reviews every question and answer afterward to check it for accuracy, and when we find an error, we correct how the box answers. Read more in How we use AI.
- Not medical advice. In an emergency, call 911, Poison Control at 1-800-222-1222, or 988.
More About Amikacin Injection on HelloPharmacist
Still have a question? A licensed pharmacist answers for free, as soon as they can.Amikacin Injection Forms and Strengths (How It Comes)
Amikacin Injection comes in 1 dose form, the injection. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Need a version that does not list lactose, a gluten source, a dye or gelatin? Inactive ingredients differ by manufacturer: see Amikacin Injection inactive ingredients by manufacturer.
Injection
How this form is used
- Amikacin sulfate injection is used for short-term treatment of serious infections caused by susceptible Gram-negative bacteria.
- Amikacin sulfate injection may also be used for certain staphylococcal infections.
- Amikacin sulfate injection may be given into a muscle or into a vein.
- For IV use, amikacin sulfate is diluted and given to adults over 30 to 60 minutes; infants receive it over 1 to 2 hours.
- Amikacin sulfate vials are single-dose, and unused portions are discarded.
- Amikacin sulfate should not be premixed with other drugs.
Amikacin Injection on the U.S. Market: Products, Makers and Brands
How Amikacin Injection appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
6 companies list 11 Amikacin Injection product records with the FDA, mostly as injection; the earliest marketing or approval year on record is 1981.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
How Widely Amikacin Injection Is Used (Medicaid Data)
How many Amikacin Injection prescriptions Medicaid paid for in Q1–Q4 2025, every brand, strength and form together. Medicaid is one program, so total U.S. use is higher.
How commonly is Amikacin Injection prescribed? Of the 1,682 medications we measure, Amikacin Injection ranks #1,170 by Medicaid prescriptions — more than 30% of them.
Utilization by Amikacin Injection product
Pick a strength and form to see its own numbers. Brand and generic versions are counted together.
4 ML amikacin 250 MG/ML Injection Most dispensed
5 of 15 listed NDCs had Medicaid claims. RxNorm 1723160
2 ML amikacin 250 MG/ML Injection
4 of 15 listed NDCs had Medicaid claims. RxNorm 1723156
Dollars are what Medicaid paid before the rebates drug makers send back, so its real cost is lower.
Source: Medicaid State Drug Utilization Data (CMS), all states. 9 of the 30 listed Amikacin Injection NDCs had Medicaid claims.
Compare Amikacin Injection Products
A representative set of FDA-listed product records for Amikacin Injection — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Injection | ||||
| 250 mg/mL | Intramuscular, Intravenous | Fresenius Kabi USA, LLC | ANDA | View NDC → |
| 250 mg/mL | Intramuscular, Intravenous | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | ANDA | View NDC → |
| 500 mg/2 mL | Intramuscular, Intravenous | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | ANDA | View NDC → |
| 1 g/4 mL | Intramuscular, Intravenous | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | ANDA | View NDC → |
| 250 mg/mL | Intramuscular, Intravenous | Hikma Pharmaceuticals USA Inc. × 2 listings | ANDA | View NDC → |
| 250 mg/mL | Intramuscular, Intravenous | Mullan Pharmaceutical Inc. × 2 listings | ANDA | View NDC → |
| 250 mg/mL | Intramuscular, Intravenous | Qilu Pharmaceutical Co., Ltd. × 2 listings | ANDA | View NDC → |
| 250 mg/mL | Intramuscular, Intravenous | Sagent Pharmaceuticals | ANDA | View NDC → |
Showing 11 of 11 products — FDA National Drug Code Directory. See every product, package size and price: browse all 11 Amikacin Injection NDCs →
Amikacin Injection Side Effects Reported to the FDA (FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Amikacin Injection — a signal of what to watch for, not proof the drug caused it.
The effects most often named in FDA reports that mention Amikacin Injection are cough, dyspnoea, therapy interrupted; about 84% of the reports were classed as serious. These are voluntary reports, so they show what people report, not how often it happens.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Amikacin Injection in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
Amikacin Injection FDA Approval History
How Amikacin Injection went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Amikacin Injection was first approved by the FDA in 1981 (Apothecon). It remains available in U.S. pharmacies today.
Source: Drugs@FDA.
Amikacin Injection Recall History
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
The FDA’s enforcement reports list no Amikacin recalls since July 2021.
✅No Amikacin recalls on record since July 2021Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Nov 19, 2026.
Amikacin Injection in RxNorm: From Ingredient to Every Form and Strength
RxNorm is the U.S. National Library of Medicine’s standard name for every version of a medicine, the code pharmacy and prescribing systems share. This page starts from one ingredient (IN); each dose form (SCDF) branches from it, and each exact strength (SCD) from its form. Combination products are separate concepts with their own pages.
- Dose forms
- 3
- Strengths
- 6
- Forms in current FDA listings
- 2 of 3
RxCUI 641 -
Dose form (SCDF) Inhalation SuspensionNo current FDA listing
RxCUI 2285804Its strength (SCD)-
70.3 mg/mL
liposomal
RxCUI 2059184
-
70.3 mg/mL
liposomal
-
Dose form (SCDF) Injectable SolutionIn current FDA listings
RxCUI 370563Its 3 strengths (SCD)-
250 mg/mL
RxCUI 1598047 -
5 mg/mL
sulfate
RxCUI 905156 -
50 mg/mL
sulfate
RxCUI 905148
-
250 mg/mL
-
Dose form (SCDF) InjectionIn current FDA listings
RxCUI 1723155Its 2 strengths (SCD)-
2 mL amikacin 250 mg/mL
RxCUI 1723156 -
4 mL amikacin 250 mg/mL
RxCUI 1723160
-
2 mL amikacin 250 mg/mL
RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
Amikacin Injection Supply and Shortage Status
Whether Amikacin Injection is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
What Amikacin Injection Costs Pharmacies (NADAC Benchmark)
What pharmacies pay to buy Amikacin Injection: the national average from CMS’s weekly NADAC survey, as of Nov 18, 2026. It is the pharmacy’s cost, not your price at the counter.
How the Pharmacy Price Has Changed
Pick a strength to see how its price has changed since Apr 2025.
For the generic 250 mg/mL injection, pharmacies paid an average of $2.57 per mL as of Nov 18, 2026, down 13% from $2.96 a year earlier.
- What pharmacies pay now
- $2.57
- per mL, as of Nov 18, 2026
- Last 4 weeks
- Up 5.6%
- from $2.43 on Oct 21, 2026
- Last 12 months
- Down 13%
- from $2.96 on Nov 19, 2025
- Lowest and highest since Apr 2025
- $2.27 to $3.21
- per mL
See the numbers, month by month
| Month | Pharmacy price |
|---|---|
| Nov 2026 | $2.57 |
| Oct 2026 | $2.43 |
| Sep 2026 | $2.33 |
| Aug 2026 | $2.30 |
| Jul 2026 | $2.27 |
| Jun 2026 | $2.27 |
| May 2026 | $2.72 |
| Apr 2026 | $2.72 |
| Mar 2026 | $2.72 |
| Feb 2026 | $2.72 |
| Jan 2026 | $2.72 |
| Dec 2025 | $2.72 |
| Nov 2025 | $2.96 |
| Oct 2025 | $2.87 |
| Sep 2025 | $3.03 |
| Aug 2025 | $3.02 |
| Jul 2025 | $3.21 |
| Jun 2025 | $3.15 |
| May 2025 | $3.15 |
| Apr 2025 | $3.05 |
| Form | Strength | Version | What pharmacies pay | |
|---|---|---|---|---|
| Injection · Intramuscular, Intravenous | 250 mg/mL | Generic | $2.57 per mL | NDC details & price history |
| Injection · Intramuscular, Intravenous | 500 mg/2 mL | Generic | $2.57 per mL | NDC details & price history |
Source: CMS National Average Drug Acquisition Cost (NADAC). Each row spans the package sizes CMS priced; the generic and the brand are priced separately.
Amikacin Injection Brand Names
Amikacin Injection has one brand name on record: Amikin. A brand name is one company's name for the medicine; a generic has the same active ingredient under its generic name.
Who Makes Amikacin Injection: Manufacturers and Labelers
6 companies list Amikacin Injection products with the FDA. By number of product records, the largest are Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc., Hikma Pharmaceuticals USA Inc., Mullan Pharmaceutical Inc.. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.
Sources for This Amikacin Injection Page
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How this page is built
HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. Sagent Pharmaceuticals is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →